SCHEMBL19987745

SCHEMBL19987745

COc1cc2nccc(Oc3ccc(N(C(=O)C4(C(N)=O)CC4)c4ccc(F)cc4)cc3F)c2cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 13/20 0.49
MET P08581 13/20 0.49
KDR P35968 4/20 0.49
MERTK Q12866 8/20 0.47
RET P07949 3/20 0.42
KIT P10721 3/20 0.42
FLT3 P36888 3/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
PDGFRB P09619 2/20 0.42
AURKA O14965 2/20 0.42
RIPK2 O43353 2/20 0.42
ABL1 P00519 2/20 0.42
EGFR P00533 2/20 0.42
ERBB2 P04626 2/20 0.42
NTRK1 P04629 2/20 0.42
LCK P06239 2/20 0.42
LYN P07948 2/20 0.42
HCK P08631 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22194083 0.90 AXL (0.45) AXLMETKDRMERTKRET
SCHEMBL408158 0.89 MET (0.62) AXLMETKDRMERTKRET
SCHEMBL31412944 0.89 MET (0.62) AXLMETKDRMERTKRET
SCHEMBL20478188 0.89 MET (0.46) AXLMETKDRMERTKRET
SCHEMBL19987751 0.88 MET (0.45) AXLMETKDRMERTKRET
SCHEMBL29728994 0.88 MET (0.45) AXLMETKDRMERTKRET
SCHEMBL19987747 0.87 AXL (0.40) AXLMETKDRMERTKRET
SCHEMBL372297 0.87 AXL (0.55) AXLMETKDRMERTKRET
SCHEMBL374207 0.87 AXL (0.55) AXLMETKDRMERTKRET
SCHEMBL31412940 0.87 AXL (0.55) AXLMETKDRMERTKRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10710996-B2 Pyrido-azaheterecydic compound and preparation method and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2020-07-14 US claimed
US-20180244667-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2018-08-30 US claimed
EP-3299369-B1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2020-11-11 EP disclosed
US-10710996-B2 Pyrido-azaheterecydic compound and preparation method and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2020-07-14 US disclosed
US-20180244667-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2018-08-30 US disclosed
EP-3299369-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2018-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180244667-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF MET, MERTK, DMPK AXL 212/4885MET 1/4885KDR 210/4885
US-10710996-B2 Pyrido-azaheterecydic compound and preparation method and use thereof MET, MERTK, DMPK AXL 212/4885MET 1/4885KDR 210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.